- Home
- EKSO vs POAI Comparison
EKSO vs POAI Comparison
Compare EKSO & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EKSO
- POAI
- Stock Information
- Founded
- EKSO 2005
- POAI 2002
- Country
- EKSO United States
- POAI United States
- Employees
- EKSO N/A
- POAI N/A
- Industry
- EKSO Medical/Dental Instruments
- POAI Industrial Specialties
- Sector
- EKSO Health Care
- POAI Health Care
- Exchange
- EKSO Nasdaq
- POAI Nasdaq
- Market Cap
- EKSO 7.7M
- POAI 6.5M
- IPO Year
- EKSO N/A
- POAI N/A
- Fundamental
- Price
- EKSO $4.04
- POAI $5.85
- Analyst Decision
- EKSO Strong Buy
- POAI Hold
- Analyst Count
- EKSO 2
- POAI 1
- Target Price
- EKSO $7.75
- POAI N/A
- AVG Volume (30 Days)
- EKSO 51.6K
- POAI 34.5K
- Earning Date
- EKSO 10-28-2025
- POAI 11-14-2025
- Dividend Yield
- EKSO N/A
- POAI N/A
- EPS Growth
- EKSO N/A
- POAI N/A
- EPS
- EKSO N/A
- POAI N/A
- Revenue
- EKSO $14,749,000.00
- POAI $1,322,628.00
- Revenue This Year
- EKSO N/A
- POAI $486.27
- Revenue Next Year
- EKSO $49.96
- POAI $65.50
- P/E Ratio
- EKSO N/A
- POAI N/A
- Revenue Growth
- EKSO N/A
- POAI 79.36
- 52 Week Low
- EKSO $2.73
- POAI $4.76
- 52 Week High
- EKSO $14.97
- POAI $45.90
- Technical
- Relative Strength Index (RSI)
- EKSO 40.70
- POAI 39.80
- Support Level
- EKSO $3.86
- POAI $5.50
- Resistance Level
- EKSO $4.32
- POAI $6.72
- Average True Range (ATR)
- EKSO 0.40
- POAI 0.80
- MACD
- EKSO -0.13
- POAI -0.08
- Stochastic Oscillator
- EKSO 15.50
- POAI 41.44
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.